Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinosarcoma × pamiparib × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gynecologic 1

Conditions

Ovarian Neoplasms 6 Carcinosarcoma 1 Carcinoma, Ovarian Epithelial 1

Interventions

Specimen Handling 6 Paclitaxel 5 Magnetic Resonance Spectroscopy 5 Nivolumab 4 Carboplatin 4 Biopsy 4 pembrolizumab 2 olaparib 2 ceralasertib 2 Taxes 2 trastuzumab deruxtecan 1 sargramostim 1 rucaparib 1 ribociclib 1 pelcitoclax 1 pamiparib 1 durvalumab 1 cobimetinib 1 cediranib 1 cabozantinib 1 belinostat 1 atezolizumab 1 X-Rays 1 Tissue Banks 1 TIC10 compound 1 Ipilimumab 1 Immunoglobulin G 1 Ifosfamide 1 Fulvestrant 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03933761 2021-08-10

PRECISE

Australia New Zealand Gynaecological Oncology Group

Phase 2 Withdrawn

GynecologicSarcoma

Carcinosarcoma, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡